Semeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease

Lawitz EJ, Poordad F, Gutierrez JA, Kakuda TN, Picchio G, Beets G, et al. Semeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease. J Viral Hepat. 2016 Nov 23th ed. 2017;24(4):287-294.

Publication Type:

Journal Article

Source:

J Viral Hepat., Volume 24, Issue 4, p.287-294 (2017)

Notes:

PMID: 27878906

Top